NASDAQ
10.50USD
-0.03 (-0.28%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
61.3M
P/E
—
EPS
—
Beta
0.26
52W range
8.56-14.76
Day range
10.50–10.79
Open
10.79
Prev close
10.53
Volume
809
Avg volume
4.1K
Dividend
0.06
IPO
1983-07-25
https://www.globenewswire.com/news-release/2026/07/30/3335716/0/en/Daxor-Broadens-Outpatient-Footprint-with-Initiation-of-ezBVA-Lab-Diagnostic-Services-in-Kansas.html · 7/30/2026+0.80
https://www.globenewswire.com/news-release/2025/10/21/3170103/0/en/Daxor-CEO-Michael-Feldschuh-to-Engage-Investors-at-Exclusive-Maxim-Growth-Summit.html · 10/21/2025+0.30
https://www.globenewswire.com/news-release/2025/09/30/3158517/0/en/Daxor-Unveils-New-FDA-Cleared-BVA-Analyzer-Amid-Strong-Market-Demand-and-Pivotal-Clinical-Data-at-HFSA.html · 9/30/2025+1.00
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
